Advertisement
Advertisement

OPRX

OPRX logo

OptimizeRx Corporation Common Stock

12.59
USD
Sponsored
-0.26
-2.06%
Jan 15, 15:59 UTC -5
Closed
exchange

After-Market

12.58

-0.01
-0.04%

OPRX Earnings Reports

Positive Surprise Ratio

OPRX beat 28 of 35 last estimates.

80%

Next Report

Date of Next Report
Mar 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$31.72M
/
$0.23
Implied change from Q3 25 (Revenue/ EPS)
+21.70%
/
+15.00%
Implied change from Q4 24 (Revenue/ EPS)
-1.84%
/
-23.33%

OptimizeRx Corporation Common Stock earnings per share and revenue

On Nov 06, 2025, OPRX reported earnings of 0.20 USD per share (EPS) for Q3 25, beating the estimate of 0.04 USD, resulting in a 342.48% surprise. Revenue reached 26.07 million, compared to an expected 24.31 million, with a 7.23% difference. The market reacted with a -17.37% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 31.72 million USD, implying an increase of 15.00% EPS, and increase of 21.70% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Simulations Plus, Inc.
Report Date
Jan 08, 2026 For Q1 26
Estimate
$0.13
Actual
$0.03
Surprise
-77.15%
FAQ
For Q3 2025, OptimizeRx Corporation Common Stock reported EPS of $0.20, beating estimates by 342.48%, and revenue of $26.07M, 7.23% above expectations.
The stock price moved down -17.37%, changed from $18.94 before the earnings release to $15.65 the day after.
The next earning report is scheduled for Mar 10, 2026.
Based on 9 analysts, OptimizeRx Corporation Common Stock is expected to report EPS of $0.23 and revenue of $31.72M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement